This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Legend Biotech Ireland Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Fei Sun: Innovator in Cancer Treatment
Introduction
Fei Sun is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of single-domain antibodies.
Latest Patents
Fei Sun holds a patent for "Single-domain antibodies against CD33 and constructs thereof." This patent provides single-domain antibodies targeting CD33, along with constructs that include chimeric receptors, immune effector cell engagers, and immunoconjugates. The application also details engineered immune cells, such as T cells, that comprise an anti-CD33 chimeric receptor and potentially a second chimeric receptor targeting an additional antigen or epitope. Furthermore, the patent outlines pharmaceutical compositions, kits, and methods for treating cancer.
Career Highlights
Fei Sun is associated with Legend Biotech Ireland Limited, where he continues to advance his research in immunotherapy. His work focuses on developing innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Fei Sun collaborates with notable colleagues, including Yafeng Zhang and Tailan Zhan, who contribute to his research efforts and enhance the impact of his work in the field.
Conclusion
Fei Sun's contributions to cancer treatment through his patented innovations highlight his role as a leading inventor in the biotechnology sector. His work continues to pave the way for advancements in immunotherapy and cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile